Four-Year watch: can new treatment save hemophilia Patients' joints?

NCT ID NCT04293523

Summary

This study is observing 427 people with hemophilia A over four years to see if long-term treatment with Elocta helps protect their joints from damage. Participants are already using Elocta as part of their regular care. The main goal is to see if this treatment reduces joint bleeds and prevents long-term joint problems in a real-world setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AUSL Romagna Centro Emofilia U.O.C., Medicina Trasfusionale Dipartimento Patologia, Clinica Ospedale M. Bufalini

    Cesena, Italy

  • Azienda Ospedaliera Città della Salute e della Scienza di Torino Regina Margherita

    Torino, Italy

  • Charité-Universitätsmedizin Berlin Campus Virchow Klinikum

    Berlin, Germany

  • Complejo Hospitalario de Navarra

    Navarro, Spain

  • Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital Malmö

    Malmo, Sweden

  • Dept. of Pediatric Haematology and Oncology, University Hospital Motol

    Prague, Czechia

  • Dr Suliman Al Habib Hospital Riyadh

    Riyadh, Saudi Arabia

  • East Kent Hospitals University NHS Foundation Trust, Kent Haemophilia and Thrombosis Centre, Kent and Canterbury Hospital

    Canterbury, United Kingdom

  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Giannina Gaslini Institute

    Genova, Italy

  • Great Ormond Street Hospital, Royal London Hospital for Integrated Medicine

    London, United Kingdom

  • HZRM Hämöphilie Zentrum Rhein Main

    Mörfelden-Walldorf, Germany

  • Helsinki University Central Hospital, New Children Hospital

    Helsinki, Finland

  • Hematologimottagning Sahlgrenska

    Gothenburg, Sweden

  • Hospital Alvaro Cunqueiro

    Vigo, Spain

  • Hospital Universitario Carlos Haya

    Málaga, Spain

  • Hospital Universitario Central de Asturias (HUCA)

    Oviedo, Spain

  • Hospital Universitario Cruces

    Cruces, Spain

  • Hospital Universitario Donostia

    Donostia / San Sebastian, Spain

  • Hospital Universitario Son Espases

    Palma de Mallorca, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Vall d'Hebron

    Barcelona, Spain

  • Hospital Virgen de la Arrixaca

    Murcia, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Spain

  • Hämostaseologie/Hämophiliezentrum, Medizinische Klinik 2 Institut für Transfusionsmedizin, Universitätsklinikum

    Frankfurt, Germany

  • Ippokrateio Hospital Thessaloniki (adult department)

    Thessaloniki, Greece

  • Ippokrateio Hospital Thessaloniki (pediatric department)

    Thessaloniki, Greece

  • Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital am Universitätsklinikum München

    München, Germany

  • King Faisal Specialised Hospital, KFSH Riyadh, Children

    Riyadh, Saudi Arabia

  • King Faisal Specialist Hospital KFSH, Adults

    Riyadh, Saudi Arabia

  • Lastehaigla, Tallinn (Tallinn Children´s Hospital)

    Tallinn, Estonia

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Riyadh Military Hospital (P.S.M.C)

    Riyadh, Saudi Arabia

  • SRH-Klinikum Heidelberg

    Heidelberg, Germany

  • Sant Johan De Deu

    Barcelona, Spain

  • Service et Laboratoire central d'hématologie, Adults

    Lausanne, Switzerland

  • The North Estonia Medical Centre Hematoloogiakeskus, Regionalhaigla

    Tallinn, Estonia

  • The Royal Hospital

    Muscat, Oman

  • Turku University Central Hospital, Paediatric and adolescent haematology and oncology clinic

    Turku, Finland

  • University Hospital Brno

    Brno, Czechia

  • University Hospital Ostrava

    Ostrava, Czechia

  • University Hospital of Parma, AOUP, Haemophilia Center

    Parma, Italy

  • University Medical Center Groningen/UMCG

    Groningen, Netherlands

  • University Medical Centre Ljubljana Division of Paediatrics

    Ljubljana, Slovenia

  • University of Bari Aldo Moro (Centro Emofilia Policlinico - Pediatria U.O.)

    Bari, Italy

  • Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Inselspital

    Bern, Switzerland

  • Universitätsklinikum Bonn AöR, Institut für Experimentelle Hämatologie und Transfusionsmedizin

    Bonn, Germany

  • Universitätsklinikum Frankfurt - Klinik für Kinder- und Jugendmedizin

    Frankfurt, Germany

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

    Hamburg, Germany

  • Universitätsspital Zürich Klinik für Medizinische Onkologie und Hämatologie

    Zurich, Switzerland

  • Uo Malattie Emorragiche e Trombotiche Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universitá Catolica del Sacro Coure

    Rome, Italy

  • Werlhof-Institut für Hämostaseologie GmbH

    Hanover, Germany

  • Zentrum für Labormedizin

    Sankt Gallen, Switzerland

Conditions

Explore the condition pages connected to this study.